CureVac starts Phase 3 clinical trial of its Covid-19 vaccine candidate
December 14, 2020 at 07:56 AM EST
Tübingen-based CureVac said the Phase 3 trial will include more than 35,000 volunteers in Europe and Latin America
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|